Neurobiological Tech (NTII) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Neurobiological Tech (NTII)

NTII 0.0001000

0.0%

Dec 26 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: diablo who wrote (198)	12/10/1997 4:32:00 PM
From: Dr. John M. de Castro	Read Replies (3) of 1494

I suspect that the selling reflects an expectation that NTII will be delisted from NASDAQ along with some tax loss selling. There is no news driving this. As John Dwyer posted earlier, they are out of compliance with the NASDAQ listing requirements. We should be hearing results from the Memantine for Neuropathic Pain Phase II trial in January. So, if they can remain listed till then, positive results should buoy the stock and allow for a decent scondary. I'm a true believer in memantine, so I intend to stay long regardless of their listing status. John de C

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next